Abaloparatide 3mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Abaloparatide supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF112025073

Key analytical results include:

• Assay Content: 3.80 mg
• Identification – Retention Time: 0.997
• Identification – Spectrum: 996
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: 0.003 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Abaloparatide is a synthetic peptide research compound studied in controlled laboratory environments focused on peptide-mediated signalling pathways and receptor interaction systems.

The compound belongs to a class of peptide analogues investigated in biochemical research for their interaction with regulatory signalling networks and receptor-mediated processes.

This preparation contains 3 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, Abaloparatide is frequently referenced in experimental peptide research models.

Compound Overview

Abaloparatide is a synthetic peptide analogue studied in biochemical research for its interaction with receptor-mediated signalling systems.

Within experimental models, the compound is commonly investigated for its interaction with peptide receptor pathways and related regulatory signalling systems.

Due to its defined molecular structure and receptor interaction profile, the compound is frequently used in laboratory studies examining peptide-mediated signalling and regulatory mechanisms.

Historical Background and Scientific Context

Scientific interest in peptide-based signalling compounds expanded during the late twentieth century as researchers began identifying hormones and regulatory peptides involved in physiological signalling systems.

This led to the development of synthetic peptide analogues that could be studied under controlled laboratory conditions to better understand receptor interactions and signalling pathways.

These developments enabled researchers to investigate peptide-receptor dynamics and signalling mechanisms in highly controlled experimental environments.

Mechanistic Focus in Research

Within experimental laboratory settings, Abaloparatide is commonly studied in relation to peptide-mediated signalling pathways.

Research investigations commonly explore the compound in experimental models examining:

• Peptide receptor signalling pathways
• Regulatory signalling networks
• Peptide receptor interaction dynamics
• Intracellular signalling mechanisms
• Comparative peptide research models
• Molecular signalling pathway analysis
• Regulatory peptide interaction modelling

These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated regulatory processes.

Research Applications

In controlled research environments, Abaloparatide may be utilised in experimental models designed to explore peptide signalling systems and receptor interactions.

Examples of research applications include:

• Peptide signalling pathway investigation
• Receptor interaction research
• Intracellular signalling network modelling
• Comparative peptide compound studies
• Molecular regulatory pathway analysis
• Controlled in vitro research studies
• Laboratory-based signalling analysis

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.8 % purity confirmed by COA
• Assay content verified at 3.80 mg
• Endotoxin level measured at 0.003 EU/mg
• No detectable heavy metals or microbial contamination
• High-purity peptide for controlled laboratory research
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.